Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer

Journal of Surgical Oncology

Volumn 105, Issue 4, 2012, Pages 400-404

  Wang, Jin ^a   Yu, Jian Chun ^a   Kang, Wei Ming ^a   Ma, Zhi Qiang ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

chemotherapy; gastric cancer; lymphadenectomy; prognosis

Indexed keywords

EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; OXALIPLATIN;

ADULT; ANEMIA; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURVIVAL; CHEMOSURGERY; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; HYPERTHERMIC THERAPY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUROPATHY; NEUTROPENIA; NODE NEGATIVE GASTRIC CANCER; POSTOPERATIVE CARE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT DURATION; TUMOR VOLUME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; EPIRUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; INTRAOPERATIVE PERIOD; LEUCOVORIN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84857052196     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22089     Document Type: Article

References (27)

1. Hartgrink HH, Jansen EP, van Grieken NC, et al.: Gastric cancer. Lancet 2009; 374: 477-490.
2. Dicken BJ, Bigam DL, Cass C, et al.: Gastric adenocarcinoma: Review and considerations for future directions. Ann Surg 2005; 241: 27-39. (Pubitemid 40044837)
3. Huang KH, Chen JH, Wu CW, et al.: Factors affecting recurrence in node-negative advanced gastric cancer. J Gastroenterol Hepatol 2009; 24: 1522-1526.
4. Saito H, Kuroda H, Matsunaga T, et al.: Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol 2010; 101: 622-625.
5. Baiocchi GL, Tiberio GA, Minicozzi AM, et al.: A multicentric western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg 2010; 252: 70-73.
6. Sun Z, Li DM, Wang ZN, et al.: Prognostic significance of microscopic positive margins for gastric cancer patients with potentially curative resection. Ann Surg Oncol 2009; 16: 3028-3037.
7. Kulig J, Sierzega M, Kolodziejczyk P, et al.: Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. Br J Surg 2009; 96: 910-918.
8. Schwarz RE, Smith DD,: Clinical impact of lymphadencetomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol 2007; 14: 317-328. (Pubitemid 46175271)
9. Sun P, Xiang JB, Chen ZY,: Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg 2009; 96: 26-33.
10. Greene FL, Page AL, Fleming ID, et al.: editors. American Joint Committee on Cancer: AJCC Cancer Staging Manual, 6th edition. New York: Springer; 2002.
11. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma-2nd English Edition. Gastric Cancer 1998; 1: 10-24.
12. Shao ZH,: Anemia. In:, Lu ZY, Zhong NS, editors. Medicine, 7th edition. Beijing: People's Medical Publishing House; 2008. pp. 567-568.
13. van Belle SP, Cocquyt V,: Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Crit Rev Oncol/Hematol 2003; 47: 1-11. (Pubitemid 36802321)
14. Vaupel P, Mayer A,: Hypoxia and anemia: Effects on tumor biology and treatment resistance. Transfus Clin Biol 2005; 12: 5-10. (Pubitemid 40487494)
15. Vaupel P, Thews O, Hoeckel M,: Treatment resistance of solid tumors: Role of hypoxia and anemia. Med Oncol 2001; 18: 243-259. (Pubitemid 34044509)
16. Mullaney PJ, Wadley MS, Hyde C, et al.: Appraisal of compliance with the UICC/AJCC staging system in the staging of gastric cancer. Br J Surg 2002; 89: 1405-1408.
17. Cunningham D, Allum WH, Stenning SP, et al.: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
18. Sakuramoto S, Sasako M, Yamaguchi T, et al.: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007; 357: 1810-1820. (Pubitemid 350044801)
19. Sugarbaker PH,: Managing the peritoneal surface component of gastrointestinal cancer. Oncology (Huntingt) 2004; 18: 51-59.
20. Shimoyama S, Shimizu N, Kaminishi M,: Type-oriented intraoperative and adjuvant chemotherapy and survival after curative resection of advanced gastric cancer. World J Surg 1999; 23: 284-292. (Pubitemid 29091699)
21. Sugarbaker PH,: Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy. Int J Hyperthermia 2007; 23: 431-442. (Pubitemid 47272773)
22. Tulunay OE, Enamorado II, Kucuk O, et al.: Pilot study of intraoperative chemotherapy with cisplatin and 5-fluorouracil in patients with andvanced squamous cell carcinoma of the head and neck. Head Neck 2007; 29: 267-271. (Pubitemid 46339324)
23. Eschwege P, Dumas F, Blanchet P, et al.: Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 1995; 346: 1528-1530.
24. Zoubek A, Kovar H, Kronberger M, et al.: Mobilization of tumour cells during biopsy in an infant with Ewing sarcoma. Eur J Pediatr 1996; 155: 373-376. (Pubitemid 26117671)
25. Hansen E, Wolff N, Knuechel R, et al.: Tumor cells in blood shed from the surgical field. Arch Surg 1995; 130: 387-393.
26. Kim JH, Park JM, Jung CW, et al.: The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol 2008; 97: 125-130.
27. Yasuda K, Adachi Y, Shiraishi N, et al.: Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol 2002; 9: 771-774.